Discover how modern science is identifying gene targets against dormant Mycobacterium tuberculosis infections through advanced bioinformatics and machine learning.
Discover how computational methods are identifying plant-based compounds to fight tuberculosis by targeting the DHFR enzyme through in-silico drug discovery.
Exploring how genetic polymorphisms in metabolic enzymes influence anti-tuberculosis drug-induced hepatotoxicity and the future of personalized medicine.
Exploring how salicyl-AMS inhibits MbtA to disrupt iron acquisition in Mycobacterium tuberculosis as a novel TB treatment strategy.